Ingredion's Q3 2022 results showed strong growth with net sales up 15%. The company successfully offset higher input costs and expanded gross margins, leading to strong operating income growth. Specialty ingredients continued to grow double digits across all regions.
Net sales increased by 15% due to solid demand and dynamic price management.
Specialty ingredients grew double digits, with higher net sales and gross profit margins across all regions.
The company commissioned a new production facility in Shandong, China, doubling local starch production capacity.
European Union approved Ingredion's bioconverted Reb M stevia solutions, supporting the sugar reduction growth platform.
Ingredion expects full-year 2022 reported EPS to be in the range of $6.90 to $7.20 and adjusted EPS to be in the range of $7.00 to $7.45. The company expects full-year 2022 net sales to be up mid-double digits and adjusted operating income to be up low-double digits.